Engineered Blood Vessels May be an Option in Cardiac Bypass

Armen Hareyan's picture

Cardiac Bypass

The first-ever human use of completely biologically engineered blood vessels grown from a person's own cells could be an option for people who have vessels too damaged for heart bypass, researchers reported at the American Heart Association's Scientific Sessions 2005.

"Sheet-based tissue engineering is an opportunity for patients to have an endless supply of vessels made from their own cells for bypass or revascularization surgeries," said Todd McAllister, Ph.D., co-author of the study and president and CEO of Cytograft Tissue Engineering in Novato, Calif.

Those mostly likely to need the tissue-engineered vessels are:

  • hemodialysis patients who require shunts between arteries and veins for access to blood filtering machines that remove wastes and excess fluids;


  • lower limb bypass patients, generally amputation candidates or diabetic patients; or

  • coronary bypass patients who do not have suitable vessels for harvest.

The coronary patients make up a particularly critical group in need of options, researchers said.

In 2002, Nicolas L'Heureux, Ph.D., McAllister and Cytograft's chief scientific officer and inventor of sheet-based tissue engineering, gave a presentation on tissue-engineered blood vessels at the American Heart Association's Scientific Sessions in Chicago.

"Back then, we demonstrated the durability and clot resistance of the vessels in different animal models," McAllister said.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.